首页> 外文OA文献 >ERBB2 juxtamembrane domain (trastuzumab binding site) gene mutation is a rare event in invasive breast cancers overexpressing the ERBB2 gene

【2h】

ERBB2 juxtamembrane domain (trastuzumab binding site) gene mutation is a rare event in invasive breast cancers overexpressing the ERBB2 gene

机译：Erbb2 juxtamembrane结构域（Trastuzumab结合位点）基因突变是过表达erbb2基因的侵袭性乳腺癌的罕见事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Thaer Khoury; Wilfrido Mojica; David Hicks; Petr Starostik; Foluso Ademuyiwa; Bagirathan Janarthanan; Richard T Cheney;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. ERBB2 juxtamembrane domain (trastuzumab binding site) gene mutation is a rare event in invasive breast cancers overexpressing the ERBB2 gene [J] . Thaer Khoury, Wilfrido Mojica, David Hicks, Modern Pathology . 2011,第8期

机译：ERBB2近膜结构域（曲妥珠单抗结合位点）基因突变在过表达ERBB2基因的浸润性乳腺癌中是罕见的事件
2. Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers. [J] . Park SW, Chung NG, Han J APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica . 2010,第1期

机译：在非小细胞肺癌中，近膜活化域中EGFR，ERBB2，ERBB3和ERBB4的体细胞突变是罕见的。
3. An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers [J] . June Y. Hou, Jason D. Wright, Vuthinun Achariyapota Gynecologic Oncology Reports . 2020,第2期

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献
4. Comprehensive proteomic analyses of the effects of a novel mutation in the ErbB2 tyrosine kinase domain on breast cancer metastasis [C] . Jane OHara, Juergen Kast American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：综合蛋白质组学分析ErbB2酪氨酸激酶结构域对乳腺癌转移的影响
5. 14-3-3 zeta mediated epithelial -mesenchymal transition (EMT) contributes to ErbB2 overexpressing ductal carcinoma in situ (DCIS) progression into invasive breast cancer [D] . Lu, Jing 2008

机译：14-3-3 Zeta介导的上皮-间质转化（EMT）有助于ErbB2过表达导管原位癌（DCIS）演变为浸润性乳腺癌
6. An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers [O] . June Y. Hou, Jason D. Wright, Vuthinun Achariyapota 2020

机译：eRBB2受体抑制剂在阴道初级标志 - 环细胞腺癌腺癌S310F体细胞α2突变中的含蓄案例：乳腺癌和妇科癌症S310F体细胞α2突变的病例报告及综述文献
7. Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations [O] . Jeffrey S. Ross, Kai Wang, Christine E. Sheehan, 2013

机译：复发经典e-cadherin（CDH1） - 矫正侵入式小叶乳腺癌显示出高频HER2（ERBB2）基因突变

ERBB2 juxtamembrane domain (trastuzumab binding site) gene mutation is a rare event in invasive breast cancers overexpressing the ERBB2 gene

著录项

引文网络

相似文献

相关主题

期刊订阅